These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39234647)

  • 21. A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.
    Guo H; Sun S; Yang Y; Ma R; Wang C; Zheng S; Wang X; Li G; ;
    J Alzheimers Dis; 2024; 101(3):923-936. PubMed ID: 39240641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals.
    Wu Y; Wang X; Gu C; Zhu J; Fang Y
    Age Ageing; 2023 Sep; 52(9):. PubMed ID: 37740920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study.
    Gu D; Lv X; Shi C; Zhang T; Liu S; Fan Z; Tu L; Zhang M; Zhang N; Chen L; Wang Z; Wang J; Zhang Y; Li H; Wang L; Zhu J; Zheng Y; Wang H; Yu X;
    J Med Internet Res; 2023 Dec; 25():e49147. PubMed ID: 38039074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
    Xu L; Wu X; Chen K; Yao L
    Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.
    Mazzon G; Ajčević M; Cattaruzza T; Menichelli A; Guerriero M; Capitanio S; Pesavento V; Dore F; Sorbi S; Manganotti P; Marini A
    Curr Alzheimer Res; 2019; 16(6):483-494. PubMed ID: 31057108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connected speech and language in mild cognitive impairment and Alzheimer's disease: A review of picture description tasks.
    Mueller KD; Hermann B; Mecollari J; Turkstra LS
    J Clin Exp Neuropsychol; 2018 Nov; 40(9):917-939. PubMed ID: 29669461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer's disease.
    Hajjar I; Okafor M; Choi JD; Moore E; Abrol A; Calhoun VD; Goldstein FC
    Alzheimers Dement (Amst); 2023; 15(1):e12393. PubMed ID: 36777093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People.
    Konig A; Satt A; Sorin A; Hoory R; Derreumaux A; David R; Robert PH
    Curr Alzheimer Res; 2018; 15(2):120-129. PubMed ID: 28847279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech.
    Balagopalan A; Eyre B; Robin J; Rudzicz F; Novikova J
    Front Aging Neurosci; 2021; 13():635945. PubMed ID: 33986655
    [No Abstract]   [Full Text] [Related]  

  • 33. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease.
    Meilan JJG; Martinez-Sanchez F; Carro J; Carcavilla N; Ivanova O
    Curr Alzheimer Res; 2018; 15(2):111-119. PubMed ID: 28847280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
    Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
    J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connected speech as a marker of disease progression in autopsy-proven Alzheimer's disease.
    Ahmed S; Haigh AM; de Jager CA; Garrard P
    Brain; 2013 Dec; 136(Pt 12):3727-37. PubMed ID: 24142144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.